WebMar 15, 2024 · BERKELEY, US – MAINZ, Germany – [March 15, 2024] — Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today a partnership with Dr Staber & Kollegen GmbH (Labor Staber) as part of its growing network of laboratories ... WebNov 8, 2024 · Registration requirements for medical devices in Vietnam are currently in a state of transition. New rules governing the registration of medical devices were …
Mainz BioMed N.V. - eqs-news.com
WebMainz, Germany. Mainz Biomed ( NASDAQ: MYNZ) is located just west of Frankfurt in a world-renowned community for advanced DNA & Pharmaceutical research, including the home of vaccine maker BioNTech SE. The TÜV Rheinland certifies that Mainz Biomed manufactures ColoAlert according to DIN EN ISO 13485. Click here to view certificate. WebApr 11, 2024 · Mainz Biomed has a news sentiment score of 0.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and … chuknoo securities ltd
Mainz Biomed Recognizes Colorectal Cancer Awareness Month
WebMainz Biomed B.V. Ordinary Shares (MYNZ) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. WebMar 29, 2024 · BERKELEY, US MAINZ, Germany March 29, 2024 Mainz Biomed NV (NASDAQ:MYNZ) (Mainz Biomed or the Company), a molecular genetics diagnostic company specializing in the early detection of cancer ... WebFeb 16, 2024 · In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Mainz Biomed B.V. ( MYNZ – Research Report ), with a price target of $25.00. The company’s shares closed ... destiny\u0027s child wyclef jean